These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4468748)

  • 21. A tissue-culture, modified live-virus rabies vaccine for dogs: report on development and clinical trial.
    Emery JB; Elliott AY; Bordt DE; Burch GR; Kugel EE
    J Am Vet Med Assoc; 1968 Mar; 152(5):476-82. PubMed ID: 5637640
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunologic prevention of rabies. III. Experimental evaluation of the capacity of an antigen of a vaccine obtained from the brain of suckling mice].
    Vescia N; Mastroeni I; Simonetti AD; D'arca SU; Tarsitani G
    Nuovi Ann Ig Microbiol; 1974; 25(5):307-18. PubMed ID: 4465765
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of interferon induction in the protective activity of rabies vaccines.
    Wiktor TJ; Postic B; Ho M; Koprowski H
    J Infect Dis; 1972 Oct; 126(4):408-18. PubMed ID: 4561726
    [No Abstract]   [Full Text] [Related]  

  • 24. Zonal centrifuge purification of human rabies vaccine obtained on bovine fetal kidney cells. Biological results.
    Atanasiu P; Tsiang H; Reculard P; Aguilon F; Lavergne M; Adamovicz P
    Dev Biol Stand; 1978; 40():35-44. PubMed ID: 680400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The detrimental effect of formaldehyde upon the immunological efficacy of Hempt rabies vaccine (author's transl)].
    Petrović M
    Zentralbl Bakteriol Orig A; 1973 Oct; 224(4):422-7. PubMed ID: 4150107
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus.
    Gupta PK; Sharma S; Walunj SS; Chaturvedi VK; Raut AA; Patial S; Rai A; Pandey KD; Saini M
    Vet Microbiol; 2005 Jul; 108(3-4):207-14. PubMed ID: 15916870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response to neonatal genetic immunization.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    Virology; 1997 Feb; 228(2):278-84. PubMed ID: 9123835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration and purification of human rabies vaccines : results.
    Panon G; Atanasiu P
    Dev Biol Stand; 1980; 46():257-64. PubMed ID: 7364152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of interferon induced by rabies vaccines (author's transl)].
    Nozaki J; Atanasiu P
    Ann Microbiol (Paris); 1975; 126(3):381-8. PubMed ID: 1211717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Post exposure use of human diploid cell culture rabies vaccine (author's transl)].
    Kuwert EK; Marcus I; Werner J; Höher PG; Thraenhart O; Hierholzer E; Iwand A; Helm EB; Wiktor TJ; Koprowski H
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):437-58. PubMed ID: 610245
    [No Abstract]   [Full Text] [Related]  

  • 31. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
    Ferguson M; Seagroatt V; Schild GC
    Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparative isolation of purified antigens of the herpes simplex virus type I and a study of their immunogenic properties].
    Kliushnik SIu; Berezin VE; Novitskiĭ VA; Pushkarskaia NL; Zaĭdes VM
    Vopr Virusol; 1988; 33(1):48-51. PubMed ID: 2835870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Swine vesicular disease: properties of the virus strain France 1/73 (author's transl)].
    Delagneau JF; Guerche J; Adamowicz P; Prunet P
    Ann Microbiol (Paris); 1974 Dec; 125(4):559-74. PubMed ID: 4143243
    [No Abstract]   [Full Text] [Related]  

  • 34. [The preparation of rabies virus nucleocapsid specific IgG and its purification and conjugation with peroxidase or fluorescein isothiocyanate (author's transl)].
    Atanasiu P; Tsiang H; Virat J
    Ann Microbiol (Paris); 1974; 125B(1):85-98. PubMed ID: 4619766
    [No Abstract]   [Full Text] [Related]  

  • 35. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies.
    Ferguson M; Schild GC
    J Gen Virol; 1982 Mar; 59(Pt 1):197-201. PubMed ID: 6802936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cultivation of the rabies virus in the continuous kidney cell line 4647 from the green marmoset].
    Aksenova TA; Mironova LL; Grachev VP; Selimov MA; Preobrazhenskaia NK
    Vopr Virusol; 1985; 30(2):180-2. PubMed ID: 2408382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge.
    Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK
    Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of an inactivated rabies vaccine in primary dog kidney cells.
    van Wezel AL; van Steenis G
    Dev Biol Stand; 1978; 40():69-75. PubMed ID: 98375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen.
    Ghaffari G; Passalacqua DJ; Bender BS; Briggs DJ; Goodenow MM; Sleasman JW
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):880-3. PubMed ID: 11527796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.